mPharma

mPharma is a Ghana-based healthcare technology platform that offers solutions such as pharmacy and inventory management for individuals and pharmacists.

Business Model:

Revenue: $10M

Employees: 51-200

Detailed mPharma Information

Geographic Data

mPharma headquarters map

Address: -

City: Accra

State: western region

Zip:

Country: GH

Financial Info

Stage:

undisclosed

Raised Last:

$30M

Raised Total:

$68M

Metrics

146,297Website Global Rank

547,384Website Monthly Traffic

Twitter Followers

Description

mPharma is a Ghana-based healthcare technology platform that offers solutions such as pharmacy and inventory management for individuals and pharmacists.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2019 Venture Round 1 - Esas Ventures
Esas Ventures
1/2022 Debt Financing 1 $5M Citibank
Citibank
1/2022 Series D $35M JAM Fund
Unbound
Northstar Investment
Social Capital
Novastar
1/2019 Series B 7 $9.7M Unbound
Social Capital
Peregrine Ventures
Novastar Ventures
Kli Capital
Cem Garih
4DX Ventures
11/2017 Series A 8 $6.6M Shravin Bharti Mittal
Unbound
Social Capital
Musha Ventures
Golden Palm Investments
Cem Garih
Breyer Capital
4DX Ventures
Shravin Bharti Mittal
5/2020 Series C $0 Daniel Vasella
DOMPE
CDC Group
Acuity Ventures
Alarko Ventures
Breyer Capital
Cem Garih
JAM Fund
Jim Breyer
northstar.vc
Novartis Venture Fund
Novastar Ventures
Unbound
Daniel Vasella
DOMPE
CDC Group
Acuity Ventures
Alarko Ventures
Breyer Capital
Cem Garih
JAM Fund
Jim Breyer
northstar.vc
Novartis Venture Fund
Novastar Ventures
Unbound
1/2020 Equity $17M Atrium
Golden Palm Investments
Novastar Ventures
4DX Ventures
CDC Group
Dompe Holdings
12/2018 Series B $9.7M
1/2016 Seed Round 3 $5M Social Capital
OTV
Golden Palm Investments
Social Capital
4/2019 Grant $0 Skoll Foundation
Skoll Foundation
1/2016 Seed Round 1 $200k Peregrine Ventures
6/2014 Non Equity Assistance 1 - Microsoft ScaleUp Tel Aviv
Microsoft ScaleUp Tel Aviv
1/2022 Series D $0 Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
12/2015 Seed Round 3 - Kli Capital
Golden Palm Investments
4DX Ventures
Kli Capital
Golden Palm Investments
4DX Ventures
1/2020 Venture Round $13.2M
9/2015 Pre Seed Round 1 - Alchemist Accelerator
Alchemist Accelerator
6/2014 Pre Seed Round 1 - Microsoft Accelerator
Microsoft Accelerator
5/2015 Seed -
1/2022 Funding Round $0 Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
5/2015 Seed -
1/2022 Funding Round 7 $30M Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
Golden Palm Investments
JAM Fund
Lux Capital
northstar.vc
Novastar Ventures
Social Capital
Unbound
5/2020 Series C 9 $17M Daniel Vasella
DOMPE
CDC Group
Daniel Vasella
DOMPE
CDC Group
6/2019 Venture Round 1 -
4/2019 Grant 1 $1.5M Skoll Foundation
Skoll Foundation
Announced Date Name Price
10/2021 Vine Pharmaceuticals
3/2019 Haltons Limited

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research